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Mushrooms are a vast and yet largely untapped source of powerful new pharmaceutical 
products. In particular, and most importantly for modern medicine, they represent an 
unlimited source of compow1ds with antitumor and immunostimulating properties [1]. 
Particularly, the intake of some wild mushrooms has shown to reduce the risk of breast 
cancer in Chiilese women [2]. A large number of LMW (low molecular weight) 
compollilds have been "identified in wild mushrooms incl~ding phenolic acids, 
flavonoids, tocopherols, carotenoids, sugars and fatty acids [3]. In this study we used 
AutoDock 4 [4] to perform virtual ligand screening in order to evaluate which LMW 
compounds may be involved in the inhibition of the activity of proteins related to 
human breast cancer: aromatase (EC: 1.14.14.1), estrone sulfatase (EC: 3.1.6.2) and 17-
hydroxysteroid dehydrogenase type 1 activity (17~-HSD-1; EC: . 1.1.1.62) [5]. A 
representative dataset of 43 LMW compounds was selected and molecular docking was 
performed against the three protein targets. 4-0-caffeoylquinic, naringin and lycopene 
_, 
stand out as the top ranked potential inhibitors for aromatase, estrone sulfatase and 1 7~­
HSD1, respectively. The information provided shows several interesting starting points 
for further development of inhibitors of the studied proteins, as also for the development 
of nutraceuticals or functional foods. 
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